CASI Pharmaceuticals Inc (CASI)
5.10
-0.15
(-2.86%)
USD |
NASDAQ |
Nov 22, 12:58
CASI Pharmaceuticals Revenue (Quarterly): 7.793M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.793M |
| June 30, 2024 | 3.979M |
| March 31, 2024 | 3.409M |
| December 31, 2023 | 6.874M |
| September 30, 2023 | 8.838M |
| June 30, 2023 | 9.82M |
| March 31, 2023 | 8.347M |
| December 31, 2022 | 15.26M |
| September 30, 2022 | 10.21M |
| June 30, 2022 | 8.573M |
| March 31, 2022 | 9.062M |
| December 31, 2021 | 9.158M |
| September 30, 2021 | 8.112M |
| June 30, 2021 | 7.162M |
| March 31, 2021 | 5.736M |
| December 31, 2020 | 4.822M |
| September 30, 2020 | 4.242M |
| June 30, 2020 | 2.671M |
| March 31, 2020 | 3.406M |
| December 31, 2019 | 1.344M |
| September 30, 2019 | 2.787M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.024M |
| March 31, 2015 | 0.0237M |
| December 31, 2014 | 0.0237M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.6693M |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.344M
Minimum
Dec 2019
15.26M
Maximum
Dec 2022
6.941M
Average
7.478M
Median
Revenue (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| Zai Lab Ltd | 102.26M |
| China SXT Pharmaceuticals Inc | -- |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | 13.38M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.395M |
| Total Expenses (Quarterly) | 15.88M |
| EPS Diluted (Quarterly) | -0.55 |
| Enterprise Value | 79.48M |
| Gross Profit Margin (Quarterly) | 51.91% |
| Profit Margin (Quarterly) | -107.7% |
| Earnings Yield | -43.92% |
| Normalized Earnings Yield | -46.07 |